Loading cancer entity…
Loading cancer entity…
Clinical trials
13 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07839637 | Survey on Multiple Osteochondromas and Enchondromatoses During the Transition From Paediatric Care to Adult Care(PJMOE) | completed | — | 91 | Istituto Ortopedico RizzoliOTHER | 1 | Sep 24, 2026 | clinicaltrials |
| NCT05463796 | InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer | recruiting | — | 5,000 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 17, 2026 | clinicaltrials |
| NCT07675967 | Clonal Hematopoiesis Chemotherapy and Radiation Effects Study(CH CARE) | recruiting | — | 5,000 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 30, 2026 | clinicaltrials |
| NCT07556874 | Descriptive Analysis of Surgeries in Patients With Multiple Osteochondromas(CHIROS) | recruiting |
Data updated 4 days agoSource updated Sep 24, 2026source: clinicaltrials
| — |
| 300 |
| Istituto Ortopedico RizzoliOTHER |
| 1 |
| May 15, 2026 |
| clinicaltrials |
| NCT04133285 | Registry of Multiple Osteochondromas(REM) | recruiting | — | 10,000 | Luca SangiorgiOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT06397443 | Ready to Sail: Evaluating Sailing's Feasibility as Ergotherapy(PaS) | completed | N/A | 8 | Istituto Ortopedico RizzoliOTHER | 1 | Mar 21, 2025 | clinicaltrials |
| NCT05914298 | Height, Ulnar Length and Forearm Function in Multiple Hereditary Exostoses | completed | — | 408 | Istituto Ortopedico RizzoliOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT04844697 | Resilience and Coping in a Rare Skeletal Disease Population to Face Coronavirus (COVID-19) Outbreak Distress: a Longitudinal Study(RELOAD) | completed | — | 15 | Istituto Ortopedico RizzoliOTHER | 1 | Mar 1, 2023 | clinicaltrials |
| NCT03442985 | An Efficacy and Safety Study of Palovarotene for the Treatment of MO(MO-Ped) | terminated | Phase 2 | 193 | Clementia Pharmaceuticals Inc.INDUSTRY | 12 | Aug 1, 2022 | clinicaltrials |
| NCT00474331 | Gene Mutations and Orthopaedic Symptoms Correlation of Multiple Hereditary Exostoses: Multicentre Project | suspended | — | 2,000 | University of British ColumbiaOTHER | 1 | May 18, 2022 | clinicaltrials |
| NCT00474448 | The Health-Related Quality of Life in Patients With Hereditary Multiple Exostoses | completed | — | 200 | University of British ColumbiaOTHER | 1 | May 18, 2022 | clinicaltrials |
| NCT03557567 | NGS Strategy Effectiveness in Molecular Diagnosis | completed | — | 400 | Istituto Ortopedico RizzoliOTHER | 0 | Jun 18, 2018 | clinicaltrials |
| NCT00473850 | Establishing the Genetic Profile of Multiple Hereditary Exostoses (HME) in Families of BC | terminated | — | 2,000 | University of British ColumbiaOTHER | 1 | Apr 15, 2011 | clinicaltrials |